Risk assessment of supply chain for pharmaceutical excipients with AHP-fuzzy comprehensive evaluation

References

• Monsuur F, Poncher J. Raising expectations of excipients. Chimicaoggi 2010;28:V–VI
   Web of Science ®Google Scholar
• Pifferi G, Restani P. The safety of pharmaceutical excipients. IlFarmaco 2003;58:541–50
   PubMedGoogle Scholar
• Katdare A, Chaubal MV. Excipient development for pharmaceutical, biotechnology, and drug delivery systems. Boca Raton (FL): CRC Press, 2006
   Google Scholar
• Shanmugam S, Im H, Sohn Y, et al. Enhanced oral bioavailability of paclitaxel by solid dispersion granulation. Drug Dev Ind Pharm 2015;16:1–13
   Web of Science ®Google Scholar
• Camargo JA, Sapin A, Nouvel C, et al. Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization. Drug Dev Ind Pharm 2013;39:146–55
   PubMed Web of Science ®Google Scholar
• Saha P, Kou JH. Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers. Eur J Pharm Biopharm 2000;50:403–11
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science 2004;303:1818–22
   PubMed Web of Science ®Google Scholar
• Wen Y, Meng WS. Recent in vivo evidences of particle-based delivery of small-interfering RNA (siRNA) into solid tumors. J Pharm Innov 2014;9:158–73
   PubMed Web of Science ®Google Scholar
• Wen Y, Kolonich HR, Kruszewski KM, et al. Retaining antibodies in tumors with a self-assembling injectable system. Mol Pharm 2013;10:1035–44
   PubMed Web of Science ®Google Scholar
• Balducci A, Wen Y, Zhang Y, et al. A novel probe for the non-invasive detection of tumor-associated inflammation. OncoImmunology 2013;2:e23034
   PubMed Web of Science ®Google Scholar
• Wen Y, Liu W, Bagia C, et al. Antibody-functionalized peptidic membranes for neutralization of allogeneic skin antigen-presenting cells. Acta Biomater 2014;10:4759–67
   PubMed Web of Science ®Google Scholar
• Saunders MJ, Liu W, Szent-Gyorgyi C, et al. Engineering fluorogen activating proteins into self-assembling materials. Bioconjug Chem 2013;24:803–10
   PubMed Web of Science ®Google Scholar
• Ali AA, Charoo NA, Abdallah DB. Pediatric drug development: formulation considerations. Drug Dev Ind Pharm 2014;40:1283–99
   PubMed Web of Science ®Google Scholar
• Saluja V. The regulation of pharmaceutical excipients. J Excipients Food Chem 2013;4:95–106
   Google Scholar
• Quality Risk Management (ICH Q9). (2011). EMA/INS/GMP/79766/201. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q9/Step4/Q9_Guideline.pdf [last accessed 7 Aug 2015]
   Google Scholar
• Charoo NA, Ali AA. Quality risk management in pharmaceutical development. Drug Dev Ind Pharm 2013;39:947–60
   PubMed Web of Science ®Google Scholar
• Tchankova L. Risk identification-basic stage in risk management. Environ Manag Health 2002;13:290–7
   Google Scholar
• Vose D. Quantitative risk analysis: a guide to Monte Carlo simulation modelling. John Wiley & Sons; 1996
   Google Scholar
• Covello V, Mumpower J. Risk analysis and risk management: an historical perspective. Risk Anal 1985;5:103–20
   Web of Science ®Google Scholar
• Gierling W. Presentation to PDA Conference, Munich, 10th March 2009
   Google Scholar
• IPEC–PQG, Joint IPEC–PQG Good Manufacturing Practices Guide for Pharmaceutical Excipients, 2006
   Google Scholar
• Carlin B. Quality risk management of compliant excipients. J Excipients Food Chem 2012;3:143–53
   Google Scholar
• Saaty RW. The analytic hierarchy process – what it is and how it is used? Math Model 1987;9:161–76
   Web of Science ®Google Scholar
• Kamal M, Al-Subhi Al-Harbi. Application of the AHP in project management. Project Manage 2001;19:19–27
   Google Scholar
• Cheng C, Yang LL, Hwang CL. Evaluating attack helicopter by AHP based on linguistic variable weight. Eur J Oper Res 1999;116:423–35
   Web of Science ®Google Scholar
• Enyinda CI, Dunu E, Gebremikael F. An analysis of strategic supplier selection and evaluation in a generic pharmaceutical firm supply chain. In: Annual Conference, Las Vegas 2010;17:77–91
   Google Scholar
• Bai Y, Zhang H, Hao Y. The performance of the backpropagation algorithm with varying slope of the activation function. Chaos Solitons Fractals 2009;40:69–77
   Web of Science ®Google Scholar
• Feng S, Xu L. Decision support for fuzzy comprehensive evaluation of urban development. Fuzzy Sets Syst 1999;105:1–12
   Web of Science ®Google Scholar
• Campos ACSM, Mareschal B, Almeida de AT. Fuzzy Flow Sort: an integration of the FlowSort method and Fuzzy Set Theory for decision making on the basis of inaccurate quantitative data. Inf Sci 2015;293:115–24
   Web of Science ®Google Scholar
• Zimmermann HJ. Fuzzy set theory-and its applications. New York: Springer Science & Business Media; 2001
   Google Scholar
• Lemaire J. Fuzzy insurance. ASTIN Bull 1990;20:33–55
   Google Scholar
• Liang Z, Yang K, Sun Y, et al. Decision support for choice optimal power generation projects: fuzzy comprehensive evaluation model based on the electricity market. Energy Policy 2006;34:3359–64
   Web of Science ®Google Scholar
• Tas A. A Fuzzy AHP approach for selecting a global supplier in pharmaceutical industry. Afr J Bus Manage 2009;6:5073–84
   Google Scholar
• Zhang L. Application of AHP-fuzzy comprehensive evaluation in assessment of eco-industrial Park. Dalian: Dalian University of Technology; 2006
   Google Scholar
• Wang C. Apploed research on job appraisal and performance evaluation by AHP-fuzzy comprehensive evaluation. Beijing: North China Electric Power University; 2005
   Google Scholar
• Gervais B, D’Arcy DM. Quality risk analysis in a cGMP environment: multiple models for comprehensive failure mode identification during the computer system lifecycle. Drug Dev Ind Pharm 2014;40:46–60
   PubMed Web of Science ®Google Scholar
• Carter D. Risk assessment for excipients for enhanced patient safety. Pharm Technol 2011;35:29–33
   Google Scholar
• Bu X, Zhu T, Ma Y, et al. Co-administration with cell penetrating peptide enhances the oral bioavailability of docetaxel-loaded nanoparticles. Drug Dev Ind Pharm 2015;41:764–71
   PubMed Web of Science ®Google Scholar
• Liang H, Yang Q, Deng L, et al. Phospholipid–Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel. Drug Dev Ind Pharm 2011;37:597–605
   PubMed Web of Science ®Google Scholar
• Charoo NA, Ali AA. Quality risk management in pharmaceutical development. Drug Dev Ind Pharm 2013;39:947–60
   PubMed Web of Science ®Google Scholar